Siddiqui, J., & Bowditch, S. Cost-Utility Analysis of Add-on Cannabidiol vs Usual Care Alone for the Treatment of Seizures in Patients With Treatment-Resistant Lennox-Gastaut Syndrome or Dravet Syndrome in the Netherlands. Columbia Data Analytics, LLC.
Chicago Style (17th ed.) CitationSiddiqui, Jamshaed, and Sally Bowditch. Cost-Utility Analysis of Add-on Cannabidiol Vs Usual Care Alone for the Treatment of Seizures in Patients With Treatment-Resistant Lennox-Gastaut Syndrome or Dravet Syndrome in the Netherlands. Columbia Data Analytics, LLC.
MLA (9th ed.) CitationSiddiqui, Jamshaed, and Sally Bowditch. Cost-Utility Analysis of Add-on Cannabidiol Vs Usual Care Alone for the Treatment of Seizures in Patients With Treatment-Resistant Lennox-Gastaut Syndrome or Dravet Syndrome in the Netherlands. Columbia Data Analytics, LLC.